DIN 02403390 — STIVARGA 40 MG
STIVARGA is a tablet of Regorafenib marketed by BAYER INC. The full Regorafenib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02403390
- Brand name
- STIVARGA
- Active ingredient
- Regorafenib
- Strength
- 40 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BAYER INC
- Health Canada status
- MARKETED
- Drug class
- Multikinase inhibitor (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.